{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:46Z","timestamp":1792427686381,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adeno-associated virus serotype 2 (AAV2) remains one of the most common vectors for CNS gene delivery. Yet, its long-term intraparenchymal trafficking and the relationship between capsid persistence and transgene expression remain poorly understood. In this study, we tracked the spatial and temporal patterns of AAV2 following direct striatal infusion in rats, analyzing tissue at 3 days, 3 weeks, 12 weeks, 30 weeks, and 67 weeks after injection. Using immunofluorescence for the human aromatic L-amino acid decarboxylase (AADC) transgene and an epitope detecting intact AAV2 capsids (A20), we mapped capsid localization, clearance, and axonal transport over more than a year. Following direct striatal infusion, AAV2 capsids rapidly localized to striatal neurons, with early accumulation in the substantia nigra pars reticulata (SNpr) detectable by 3 days post-infusion, but without evidence of nigral neuron transduction. Transgene expression increased over time and peaked locally at 12 weeks, with a delayed yet robust AADC signal in striatonigral terminals by 30 weeks. By 67 weeks, capsid signal was minimal while AADC expression remained stable. These findings clarify the long-term dynamics of AAV2 distribution, capsid persistence, and axonal transport in the adult brain, informing our understanding of vector behavior and durability following intraparenchymal AAV2 gene delivery.<\/jats:p>","DOI":"10.1038\/s41434-026-00617-1","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:42Z","timestamp":1777509762000},"page":"628-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AAV2 capsid clearance and neuronal trafficking dynamics in the central nervous system"],"prefix":"10.1038","volume":"33","author":[{"given":"Thanvi","family":"Gullapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake W.","family":"Willows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Karkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-9164","authenticated-orcid":false,"given":"Vikas","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5025-7540","authenticated-orcid":false,"given":"Abigail","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya E.","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6724-9925","authenticated-orcid":false,"given":"Meika","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8769-1439","authenticated-orcid":false,"given":"Anitvir S.","family":"Taunque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy L.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-473X","authenticated-orcid":false,"given":"Lluis","family":"Samaranch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"617_CR1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1073\/pnas.79.6.2077","volume":"79","author":"RJ Samulski","year":"1982","unstructured":"Samulski RJ, Berns KI, Tan M, Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci USA. 1982;79:2077\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O\u2019Malley KL, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994;8:148\u201354.","journal-title":"Nat Genet"},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","volume":"713","author":"TJ McCown","year":"1996","unstructured":"McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 1996;713:99\u2013107.","journal-title":"Brain Res"},{"key":"617_CR4","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial. Lancet. 2007;369:2097\u2013105.","journal-title":"Lancet"},{"key":"617_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.expneurol.2008.03.004","volume":"211","author":"KM Bishop","year":"2008","unstructured":"Bishop KM, Hofer EK, Mehta A, Ramirez A, Sun L, Tuszynski M, et al. Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons. Exp Neurol. 2008;211:574\u201384.","journal-title":"Exp Neurol"},{"key":"617_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"WJ Marks Jr","year":"2010","unstructured":"Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, et al. Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010;9:1164\u201372.","journal-title":"Lancet Neurol"},{"key":"617_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. BioDrugs. 2017;31:317\u201334.","journal-title":"BioDrugs"},{"key":"617_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41434-018-0010-2","volume":"25","author":"AH Nagahara","year":"2018","unstructured":"Nagahara AH, Wilson BR, Ivasyk I, Kovacs I, Rawalji S, Bringas JR, et al. MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene Ther. 2018;25:104\u201314.","journal-title":"Gene Ther"},{"key":"617_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.25450","volume":"85","author":"CW Christine","year":"2019","unstructured":"Christine CW, Bankiewicz KS, Van Laar AD, Richardson RM, Ravina B, Kells AP, et al. Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease. Ann Neurol. 2019;85:704\u201314.","journal-title":"Ann Neurol"},{"key":"617_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24524-8","volume":"12","author":"TS Pearson","year":"2021","unstructured":"Pearson TS, Gupta N, San Sebastian W, Imamura-Ching J, Viehoever A, Grijalvo-Perez A, et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. 2021;12:4251.","journal-title":"Nat Commun"},{"key":"617_CR11","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/WNL.0000000000012952","volume":"98","author":"CW Christine","year":"2022","unstructured":"Christine CW, Richardson RM, Van Laar AD, Thompson ME, Fine EM, Khwaja OS, et al. Safety of AADC Gene Therapy for moderately advanced parkinson disease: three-year outcomes from the PD-1101 Trial. Neurology. 2022;98:e40\u2013e50.","journal-title":"Neurology"},{"key":"617_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/mds.30193","volume":"40","author":"AD Van Laar","year":"2025","unstructured":"Van Laar AD, Christine CW, Phielipp N, Larson PS, Elder JB, Merola A, et al. Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson\u2019s Disease. Mov Disord. 2025;40:1297\u2013306.","journal-title":"Mov Disord"},{"key":"617_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1073\/pnas.70.1.215","volume":"70","author":"FJ Koczot","year":"1973","unstructured":"Koczot FJ, Carter BJ, Garon CF, Rose JA. Self-complementarity of terminal sequences within plus or minus strands of adenovirus-associated virus DNA. Proc Natl Acad Sci USA. 1973;70:215\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR14","first-page":"1","volume":"218","author":"KI Berns","year":"1996","unstructured":"Berns KI, Giraud C. Biology of adeno-associated virus. Curr Top Microbiol Immunol. 1996;218:1\u201323.","journal-title":"Curr Top Microbiol Immunol"},{"key":"617_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000060327","volume":"4","author":"RM Linden","year":"2000","unstructured":"Linden RM, Berns KI. Molecular biology of adeno-associated viruses. Contrib Microbiol. 2000;4:68\u201384.","journal-title":"Contrib Microbiol"},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","volume":"72","author":"C Summerford","year":"1998","unstructured":"Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol. 1998;72:1438\u201345.","journal-title":"J Virol"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","volume":"77","author":"SR Opie","year":"2003","unstructured":"Opie SR, Warrington KH Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol. 2003;77:6995\u20137006.","journal-title":"J Virol"},{"key":"617_CR18","doi-asserted-by":"publisher","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","volume":"77","author":"A Kern","year":"2003","unstructured":"Kern A, Schmidt K, Leder C, M\u00fcller OJ, Wobus CE, Bettinger K, et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol. 2003;77:11072\u201381.","journal-title":"J Virol"},{"key":"617_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/4768","volume":"5","author":"C Summerford","year":"1999","unstructured":"Summerford C, Bartlett JS, Samulski RJ. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med. 1999;5:78\u201382.","journal-title":"Nat Med"},{"key":"617_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay S, Meyer NL, Puschnik AS, Davulcu O, Diep J, Ishikawa Y, et al. An essential receptor for adeno-associated virus infection. Nature. 2016;530:108\u201312.","journal-title":"Nature"},{"key":"617_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/mt.2016.49","volume":"24","author":"C Summerford","year":"2016","unstructured":"Summerford C, Johnson JS, Samulski RJ. AAVR: A Multi-Serotype Receptor for AAV. Mol Ther. 2016;24:663\u20136.","journal-title":"Mol Ther"},{"key":"617_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.coviro.2017.06.003","volume":"24","author":"S Pillay","year":"2017","unstructured":"Pillay S, Carette JE. Host determinants of adeno-associated viral vector entry. Curr Opin Virol. 2017;24:124\u201331.","journal-title":"Curr Opin Virol"},{"key":"617_CR23","doi-asserted-by":"publisher","unstructured":"Pillay S, Zou W, Cheng F, Puschnik AS, Meyer NL, Ganaie SS, et al. Adeno-associated Virus (AAV) Serotypes have distinctive interactions with domains of the cellular AAV receptor. J Virol. 2017;91. https:\/\/doi.org\/10.1128\/jvi.00391-17.","DOI":"10.1128\/jvi.00391-17"},{"key":"617_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chom.2011.10.014","volume":"10","author":"M Nonnenmacher","year":"2011","unstructured":"Nonnenmacher M, Weber T. Adeno-associated virus 2 infection requires endocytosis through the CLIC\/GEEC pathway. Cell Host Microbe. 2011;10:563\u201376.","journal-title":"Cell Host Microbe"},{"key":"617_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1099\/0022-1317-83-5-973","volume":"83","author":"A Girod","year":"2002","unstructured":"Girod A, Wobus CE, Z\u00e1dori Z, Ried M, Leike K, Tijssen P, et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol. 2002;83:973\u20138.","journal-title":"J Gen Virol"},{"key":"617_CR26","doi-asserted-by":"publisher","first-page":"11040","DOI":"10.1128\/JVI.01056-06","volume":"80","author":"F Sonntag","year":"2006","unstructured":"Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA. Adeno-associated virus type 2 capsids with externalized VP1\/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J Virol. 2006;80:11040\u201354.","journal-title":"J Virol"},{"key":"617_CR27","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/JVI.02309-08","volume":"83","author":"JS Johnson","year":"2009","unstructured":"Johnson JS, Samulski RJ. Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J Virol. 2009;83:2632\u201344.","journal-title":"J Virol"},{"key":"617_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/gt.2012.6","volume":"19","author":"M Nonnenmacher","year":"2012","unstructured":"Nonnenmacher M, Weber T. Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther. 2012;19:649\u201358.","journal-title":"Gene Ther"},{"key":"617_CR29","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1128\/JVI.79.18.11776-11787.2005","volume":"79","author":"K Lux","year":"2005","unstructured":"Lux K, Goerlitz N, Schlemminger S, Perabo L, Goldnau D, Endell J, et al. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. J Virol. 2005;79:11776\u201387.","journal-title":"J Virol"},{"key":"617_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/mt.2011.250","volume":"20","author":"PJ Xiao","year":"2012","unstructured":"Xiao PJ, Li C, Neumann A, Samulski RJ. Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues. Mol Ther. 2012;20:317\u201328.","journal-title":"Mol Ther"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1128\/JVI.00935-12","volume":"86","author":"PJ Xiao","year":"2012","unstructured":"Xiao PJ, Samulski RJ. Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network. J Virol. 2012;86:10462\u201373.","journal-title":"J Virol"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1128\/JVI.02660-13","volume":"88","author":"SC Nicolson","year":"2014","unstructured":"Nicolson SC, Samulski RJ. Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus. J Virol. 2014;88:4132\u201344.","journal-title":"J Virol"},{"key":"617_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.47","volume":"2","author":"JM Kelich","year":"2015","unstructured":"Kelich JM, Ma J, Dong B, Wang Q, Chin M, Magura CM, et al. Super-resolution imaging of nuclear import of adeno-associated virus in live cells. Mol Ther Methods Clin Dev. 2015;2:15047.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"617_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/hum.2008.137","volume":"20","author":"LC Johnston","year":"2009","unstructured":"Johnston LC, Eberling J, Pivirotto P, Hadaczek P, Federoff HJ, Forsayeth J, et al. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum Gene Ther. 2009;20:497\u2013510.","journal-title":"Hum Gene Ther"},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/mt.2010.248","volume":"19","author":"A Ciesielska","year":"2011","unstructured":"Ciesielska A, Mittermeyer G, Hadaczek P, Kells AP, Forsayeth J, Bankiewicz KS. Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol Ther. 2011;19:922\u20137.","journal-title":"Mol Ther"},{"key":"617_CR36","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1128\/JVI.74.6.2777-2785.2000","volume":"74","author":"JS Bartlett","year":"2000","unstructured":"Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol. 2000;74:2777\u201385.","journal-title":"J Virol"},{"key":"617_CR37","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/JVI.75.9.4080-4090.2001","volume":"75","author":"J Hansen","year":"2001","unstructured":"Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol. 2001;75:4080\u201390.","journal-title":"J Virol"},{"key":"617_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/hum.2006.17.291","volume":"17","author":"P Hadaczek","year":"2006","unstructured":"Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J, et al. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther. 2006;17:291\u2013302.","journal-title":"Hum Gene Ther"},{"key":"617_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.gt.3302527","volume":"12","author":"W Ding","year":"2005","unstructured":"Ding W, Zhang L, Yan Z, Engelhardt JF. Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 2005;12:873\u201380.","journal-title":"Gene Ther"},{"key":"617_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","volume":"10","author":"C Burger","year":"2004","unstructured":"Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10:302\u201317.","journal-title":"Mol Ther"},{"key":"617_CR41","doi-asserted-by":"publisher","first-page":"10220","DOI":"10.1073\/pnas.1001673107","volume":"107","author":"F Sonntag","year":"2010","unstructured":"Sonntag F, Schmidt K, Kleinschmidt JA. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci USA. 2010;107:10220\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"617_CR42","doi-asserted-by":"publisher","unstructured":"Cabanes-Creus M, Liao SHY, Pardo-Pi\u00f1\u00f3n M, Rojas AL, Kelich J, Coyne J, et al. AAV2 Bypasses direct endosomal escape by using aavr to access the trans-golgi network en route to the nucleus. bioRxiv. 2025:2025.11.22.689972. https:\/\/doi.org\/10.1101\/2025.11.22.689972 (Preprint).","DOI":"10.1101\/2025.11.22.689972"},{"key":"617_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/hum.2011.220","volume":"23","author":"G Mittermeyer","year":"2012","unstructured":"Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, et al. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson\u2019s disease. Hum Gene Ther. 2012;23:377\u201381.","journal-title":"Hum Gene Ther"},{"key":"617_CR44","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","volume":"28","author":"LA George","year":"2020","unstructured":"George LA, Ragni MV, Rasko JEJ, Raffini LJ, Samelson-Jones BJ, Ozelo M, et al. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. Mol Ther. 2020;28:2073\u201382.","journal-title":"Mol Ther"},{"key":"617_CR45","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1016\/j.ymthe.2022.08.003","volume":"30","author":"MT Rocco","year":"2022","unstructured":"Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, et al. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson\u2019s disease. Mol Ther. 2022;30:3632\u20138.","journal-title":"Mol Ther"},{"key":"617_CR46","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1128\/jvi.76.5.2043-2053.2002","volume":"76","author":"Z Yan","year":"2002","unstructured":"Yan Z, Zak R, Luxton GW, Ritchie TC, Bantel-Schaal U, Engelhardt JF. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol. 2002;76:2043\u201353.","journal-title":"J Virol"},{"key":"617_CR47","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1172\/JCI8317","volume":"105","author":"D Duan","year":"2000","unstructured":"Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest. 2000;105:1573\u201387.","journal-title":"J Clin Invest"},{"key":"617_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/mt.2009.257","volume":"18","author":"JD Finn","year":"2010","unstructured":"Finn JD, Hui D, Downey HD, Dunn D, Pien GC, Mingozzi F, et al. Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction. Mol Ther. 2010;18:135\u201342.","journal-title":"Mol Ther"},{"key":"617_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41434-024-00507-4","volume":"32","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Sach T, Ong JY, Lim TA, Berecz Z, Deniston C, et al. Adeno-associated virus serotype 2 capsids with proteolytic cuts by trypsin remain intact and potent. Gene Ther. 2025;32:121\u201331.","journal-title":"Gene Ther"},{"key":"617_CR50","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1523\/JNEUROSCI.2158-19.2020","volume":"40","author":"B Zingg","year":"2020","unstructured":"Zingg B, Peng B, Huang J, Tao HW, Zhang LI. Synaptic Specificity and Application of Anterograde Transsynaptic AAV for Probing Neural Circuitry. J Neurosci. 2020;40:3250\u201367.","journal-title":"J Neurosci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00617-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:58:31Z","timestamp":1789653511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00617-1","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal procedures were approved by The Ohio State University Institutional Animal Care and Use Committee (IACUC) and conducted in accordance with institutional guidelines and the National Institutes of Health guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}